Drugs / LY2403021
last change Jul 2018 re-read 2 minutes ago

LY2403021

Developed for
type 2 diabetes mellitus

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT02792400 Comparator May → Aug 2016 type 2 diabetes mellitus University Hospital, Gentofte, Copenhagen Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LY2403021 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02792400
Action Inhibit “Glucagon receptor antagonist” NCT02792400